6N7Y
Crystal structure of human FPPS in complex with an allosteric inhibitor MIT-01-102
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | CLSI BEAMLINE 08ID-1 |
| Synchrotron site | CLSI |
| Beamline | 08ID-1 |
| Temperature [K] | 100 |
| Detector technology | CCD |
| Collection date | 2017-06-15 |
| Detector | MARMOSAIC 300 mm CCD |
| Wavelength(s) | 0.97949 |
| Spacegroup name | P 41 21 2 |
| Unit cell lengths | 111.240, 111.240, 77.300 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 78.660 - 2.000 |
| R-factor | 0.17544 |
| Rwork | 0.174 |
| R-free | 0.20244 |
| Structure solution method | FOURIER SYNTHESIS |
| Starting model (for MR) | 4xqr |
| RMSD bond length | 0.015 |
| RMSD bond angle | 1.733 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | REFMAC |
| Refinement software | REFMAC (5.8.0230) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 78.660 | 2.040 |
| High resolution limit [Å] | 2.000 | 2.000 |
| Rmerge | 0.047 | 1.385 |
| Rmeas | 0.049 | 1.447 |
| Rpim | 0.014 | 0.415 |
| Number of reflections | 33209 | 1628 |
| <I/σ(I)> | 23.2 | 1.9 |
| Completeness [%] | 99.8 | 99.3 |
| Redundancy | 13 | 11.9 |
| CC(1/2) | 0.999 | 0.826 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 295 | 1.6 M Ammonium phosphate, 20% glycerol, 0.08 M TrisHCl |






